Th22 Cells/IL-22 Serves as a Protumor Regulator to Drive Poor Prognosis through the JAK-STAT3/MAPK/AKT Signaling Pathway in Non-Small-Cell Lung Cancer

Yinan Yao(First Affiliated Hospital Zhejiang University), Jianying Zhou(Zhejiang University)
Journal of Immunology Research
May 28, 2022
Cited by 19


Related Papers